Discovery of thiadiazoles as a novel structural class of potent and selective PDE7 inhibitors. Part 1: design, synthesis and structure-activity relationship studies.

[1]  J. Y. Roberge,et al.  Identification of purine inhibitors of phosphodiesterase 7 (PDE7). , 2004, Bioorganic & medicinal chemistry letters.

[2]  J. Palacios,et al.  Alterations on phosphodiesterase type 7 and 8 isozyme mRNA expression in Alzheimer’s disease brains examined by in situ hybridization , 2003, Experimental Neurology.

[3]  P. Barnes,et al.  Ubiquitous expression of phosphodiesterase 7A in human proinflammatory and immune cells. , 2003, American journal of physiology. Lung cellular and molecular physiology.

[4]  T. Sasaki,et al.  Potential role of phosphodiesterase 7 in human T cell function: comparative effects of two phosphodiesterase inhibitors , 2002, Clinical and experimental immunology.

[5]  C. Hertel,et al.  PDE7A is expressed in human B-lymphocytes and is up-regulated by elevation of intracellular cAMP. , 2002, Cellular signalling.

[6]  J. Kotera,et al.  Novel alternative splice variants of rat phosphodiesterase 7B showing unique tissue-specific expression and phosphorylation. , 2002, The Biochemical journal.

[7]  D M Essayan,et al.  Cyclic nucleotide phosphodiesterases. , 2001, The Journal of allergy and clinical immunology.

[8]  J. Palacios,et al.  Differential distribution of cAMP‐specific phosphodiesterase 7A mRNA in rat brain and peripheral organs , 2001, Synapse.

[9]  H. Dyke,et al.  Synthesis and structure-activity relationships of guanine analogues as phosphodiesterase 7 (PDE7) inhibitors. , 2001, Bioorganic & medicinal chemistry letters.

[10]  M. I. Abasolo,et al.  CoMFA of benzyl derivatives of 2,1,3-benzo and benzothieno[3,2-alpha]thiadiazine 2,2-dioxides: clues for the design of phosphodiesterase 7 inhibitors. , 2001, European journal of medicinal chemistry.

[11]  J. Corbin,et al.  Cyclic nucleotide phosphodiesterases: relating structure and function. , 2001, Progress in nucleic acid research and molecular biology.

[12]  A. Means,et al.  Principles of Molecular Regulation , 2000, Humana Press.

[13]  J. Beavo,et al.  Regulation of cAMP and cGMP signaling: new phosphodiesterases and new functions. , 2000, Current opinion in cell biology.

[14]  J. Casacuberta,et al.  Benzyl derivatives of 2,1,3-benzo- and benzothieno[3,2-a]thiadiazine 2,2-dioxides: first phosphodiesterase 7 inhibitors. , 2000, Journal of medicinal chemistry.

[15]  J. Beavo,et al.  CD3- and CD28-dependent induction of PDE7 required for T cell activation. , 1999, Science.

[16]  M. Conti,et al.  The molecular biology of cyclic nucleotide phosphodiesterases. , 1999, Progress in nucleic acid research and molecular biology.

[17]  J. Beavo,et al.  Identification and Characterization of a Novel Family of Cyclic Nucleotide Phosphodiesterases* , 1998, The Journal of Biological Chemistry.

[18]  M. Gruttadauria,et al.  A quantitative study of substituent effects on oxidative cyclization of some 2-methylsubstituted aldehydes. Thiosemicarbazones induced by ferric chloride† , 1996 .

[19]  M. Gruttadauria,et al.  Substituent effect on oxidative cyclization of aldehyde thiosemicarbazones with ferric chloride , 1991 .

[20]  P. Molina,et al.  2-Methylthio-1,3,4-thiadiazolium cations as usefeul precursors for the preparation of 2-amino-1,3,4-thiadiazole de rivatives and as dehydrating reagents of aldoximes , 1989 .

[21]  P. Molina,et al.  Alkyl 2-Methyldithiocarbazates in Heterocyclic Synthesis: Preparation of 2-Alkylthio-1,3,4-thiadiazolium Cations and 2-Thioxo-2,3-dihydro-1,3,4-Oxadiazole Derivatives , 1988 .